Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
Melanoma represents the most aggressive skin cancer, being responsible for the majority of deaths related with these neoplasms. Despite chemotherapy represents a frontline approach for management of the advanced stages of the disease, it displayed poor response rates and short-term efficacy due to m...
Saved in:
Main Authors: | Roberto Campagna (Author), Tiziana Bacchetti (Author), Eleonora Salvolini (Author), Valentina Pozzi (Author), Elisa Molinelli (Author), Valerio Brisigotti (Author), Davide Sartini (Author), Anna Campanati (Author), Gianna Ferretti (Author), Annamaria Offidani (Author), Monica Emanuelli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
by: Oriana Simonetti, et al.
Published: (2021) -
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches
by: Monica Emanuelli, et al.
Published: (2022) -
Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
by: Stefania Fumarola, et al.
Published: (2020) -
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
by: Elisa Molinelli, et al.
Published: (2020) -
Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome
by: Gianna Ferretti, et al.
Published: (2012)